OTOLITH SOUND, INC.

Profile

Company Names

OTOLITH SOUND, INC.

Addresses

200 MASSACHUSETTS AVE NW, FL7, WASHINGTON, DC 20001

200 MASSACHUSETTS AVE NW, FLOOR 7, WASHINGTON, DC 20001

1875 CONNECTICUT AVENUE NW, 10TH FLOOR, WASHINGTON, DC 20009

1875 CONNECTICUT AVE NW, FLOOR 10, WASHINGTON, DC 20009

3400 PROSPECT ST NW, WASHINGTON, DC 20007

Phone Numbers

571-263-3498

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$30,878,908.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2024-07-29 
$4,899,055.00 
$8,917,717.00 
$4,018,662.00 
Equity 
4
2023-01-23 
$24,799,853.00 
$24,799,853.00 
$0.00 
Equity 
3
2018-10-26 
$750,000.00 
$750,000.00 
$0.00 
Equity, Debt 
2
2018-04-10 
$405,000.00 
$500,000.00 
$95,000.00 
Debt 
1
2016-06-10 
$25,000.00 
$250,000.00 
$225,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANTHONY 
 
AIUDI 
DIRECTOR
FOUNT BIO, INC.   |  BIOTHEA PHARMA, INC.   |  NEUTROLIS INC.   |  VALITOR, INC.   |  I2O THERAPEUTICS, INC.   |  ADVANCELL ISOTOPES PTY LTD   |  OTOLITH SOUND, INC.
JON 
 
AKERS 
EXECUTIVE OFFICER
OTOLITH SOUND, INC.
JOHN 
 
DAGGITT 
EXECUTIVE OFFICER
OTOLITH SOUND, INC.
DIDIER 
 
DEPIREUX 
EXECUTIVE OFFICER
OTOLITH SOUND, INC.
KEVIN 
 
FRANCK 
EXECUTIVE OFFICER
OTOLITH SOUND, INC.
THOMAS 
 
HARDART 
EXECUTIVE OFFICER
OTOLITH SOUND, INC.
TOM 
 
HARDART 
EXECUTIVE OFFICER
FP MEDTECH, INC.   |  OTOLITH SOUND, INC.
RAPHAEL 
 
MICHEL 
DIRECTOR
EARGO, INC.   |  OTOLITH SOUND, INC.
SAMUEL 
 
OWEN 
EXECUTIVE OFFICER, DIRECTOR
OTOLITH SOUND, INC.   |  2220 SAN JACINTO PARTNERS, LP
DAN 
 
WAGNER 
EXECUTIVE OFFICER
MYCARE, INC.   |  SAMI HEALTH, INC.   |  EPIEP, INC.   |  TANGEN BIOSCIENCES, INC.   |  CIVIS ANALYTICS, INC.   |  OTOLITH SOUND, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-29 
2023-02-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-23 
2018-11-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-10-26 
2018-04-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2018-04-10 
2016-06-21
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#